Stratec SE (ETR: SBS)
Germany
· Delayed Price · Currency is EUR
29.00
+0.20 (0.69%)
Dec 20, 2024, 5:35 PM CET
Stratec SE Company Description
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally.
It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.
The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Stratec SE
Country | Germany |
Founded | 2018 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 1,480 |
CEO | Marcus Wolfinger |
Contact Details
Address: Gewerbestrasse 37 Birkenfeld, 75217 Germany | |
Phone | 49 7082 7916 0 |
Website | stratec.com |
Stock Details
Ticker Symbol | SBS |
Exchange | Deutsche Börse Xetra |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | DE000STRA555 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Marcus Wolfinger | Chairman of Board of Management and Chief Executive Officer |
Dr. Claus Vielsack | Director of Product Development and Member of Board of Management |
Dr. Georg Bauer | Director for Sales and Member of Management Board |
Hermann Leistner | Founder and Advisor |
Jan Keppeler | Head of Investor Relations, Sustainability and Corporate Communications |